Sign in

Cytek Biosciences, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total revenue 0.20 0.20 0.19 0.16 0.13 0.09 0.06
Cost of revenue 0.10 0.09 0.08 0.06 0.05 0.04 0.03
Gross profit 0.10 0.11 0.11 0.10 0.08 0.05 0.03
Total operating expenses + 0.14 0.13 0.14 0.10 0.07 0.04 0.05
Operating income -0.04 -0.02 -0.03 0.00 0.01 0.01 -0.02
Non-operating income (net) 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Income before tax -0.03 -0.01 -0.02 0.00 0.01 0.01 -0.02
Income tax expense 0.04 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.07 -0.01 -0.01 0.00 0.00 0.02 -0.02
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.04 0.06 0.05 0.05 0.04 0.06 0.05 0.05 0.04 0.06 0.05 0.05 0.04 0.05 0.04 0.04 0.04 0.04 0.03 0.03 0.02 0.03 0.03 0.02 0.02
Cost of revenue 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Gross profit 0.02 0.03 0.03 0.02 0.02 0.03 0.03 0.03 0.02 0.03 0.03 0.03 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.01
Total operating expenses + 0.04 0.04 0.04 0.03 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01
Operating income -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 -0.01 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.02 0.00 -0.01 -0.01 -0.01 0.01 0.00 -0.01 -0.01 0.00 0.00 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00
Income tax expense 0.00 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00
Net income -0.02 -0.04 -0.01 -0.01 -0.01 0.01 0.00 -0.01 -0.01 0.01 -0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total cash and short-term investments + 0.26 0.28 0.26 0.34 0.36 0.17 0.03
Accounts receivable, net 0.07 0.06 0.06 0.05 0.03 0.02 0.02
Inventories 0.05 0.04 0.06 0.05 0.03 0.02 0.02
Other current assets 0.01 0.01 0.01 0.01 0.01 0.00 0.00
Total current assets 0.39 0.40 0.39 0.45 0.43 0.21 0.07
Total non-current assets + 0.07 0.10 0.10 0.07 0.03 0.01 0.00
Total assets 0.46 0.50 0.49 0.52 0.46 0.22 0.07
Total current liabilities + 0.08 0.07 0.06 0.05 0.03 0.03 0.02
Total non-current liabilities + 0.04 0.04 0.05 0.04 0.02 0.21 0.09
Total liabilities 0.12 0.10 0.10 0.09 0.06 0.24 0.11
Total stockholders' equity + 0.34 0.40 0.39 0.43 0.41 -0.02 -0.04
Common shares outstanding 128 131 135 139 134 133 133
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 0.26 0.26 0.26 0.26 0.27 0.28 0.28 0.28 0.27 0.26 0.29 0.30 0.30 0.34 0.34 0.35 0.36 0.36 0.38 0.16 0.17 0.17 0.00 0.00 0.03
Accounts receivable, net 0.06 0.07 0.06 0.06 0.06 0.06 0.05 0.04 0.05 0.06 0.06 0.05 0.05 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.02
Inventories 0.05 0.05 0.05 0.05 0.05 0.04 0.05 0.05 0.05 0.06 0.07 0.07 0.07 0.05 0.05 0.05 0.04 0.03 0.03 0.03 0.03 0.02
Other current assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Total current assets 0.38 0.39 0.39 0.38 0.38 0.40 0.39 0.38 0.39 0.39 0.42 0.42 0.43 0.45 0.44 0.44 0.44 0.43 0.44 0.22 0.21 0.21 0.03
Total non-current assets + 0.07 0.07 0.11 0.11 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.07 0.06 0.05 0.05 0.03 0.01 0.01 0.01 0.01 -0.03
Total assets 0.45 0.46 0.49 0.49 0.48 0.50 0.49 0.48 0.49 0.49 0.52 0.53 0.52 0.52 0.50 0.49 0.49 0.46 0.45 0.23 0.22 0.22
Total current liabilities + 0.08 0.08 0.08 0.07 0.07 0.07 0.06 0.05 0.06 0.06 0.06 0.05 0.06 0.05 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03
Total non-current liabilities + 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.02 0.02 0.21 0.21 0.21
Total liabilities 0.12 0.12 0.12 0.12 0.10 0.10 0.11 0.09 0.10 0.10 0.10 0.10 0.10 0.09 0.08 0.08 0.08 0.06 0.05 0.24 0.24 0.24
Total stockholders' equity + 0.33 0.34 0.38 0.38 0.38 0.40 0.39 0.39 0.39 0.39 0.42 0.42 0.42 0.43 0.42 0.41 0.41 0.41 0.40 -0.01 -0.02 -0.02 0.03
Common shares outstanding 129 128 128 127 128 129 133 131 131 131 136 136 135 137 139 134 134 114 114 131 127 123 128 128 123
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Operating cash flow + 0.00 0.03 0.01 -0.01 0.00 0.02 -0.01
Cash flow from investing + 0.01 -0.08 -0.09 -0.06 -0.02 0.00 0.00
Cash flow from financing + -0.01 -0.02 -0.04 0.01 0.21 0.12 0.00
Change in cash -0.01 -0.07 -0.13 -0.06 0.20 0.14 -0.01
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.01 -0.01 -0.01 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Cash flow from investing + -0.03 0.00 0.02 -0.02 0.01 -0.06 -0.02 0.00 -0.01 0.03 0.04 0.00 -0.17 -0.05 0.00 0.00 0.00 -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.00 0.00 -0.01 0.00 -0.01 0.00 0.00 -0.03 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.00 0.00 0.12 0.00 0.00 0.00
Change in cash -0.03 0.00 0.02 -0.02 0.00 -0.07 -0.01 0.01 0.00 0.00 0.03 0.00 -0.17 -0.04 -0.01 -0.01 0.00 -0.01 0.22 -0.01 0.00 0.13 0.00 0.00 0.00
5 days ago

Cytek Biosciences, Inc. (CTKB) - Total Revenue

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Gross Profit

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Other Non Operating Income

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Net Income

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Ebitda

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Ebit

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Net Income From Continuing Operations

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Income Tax Expense

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Income Before Tax

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Depreciation And Amortization

1Y 2Y 5Y Max
9 days ago